Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.28	121.33	68.79	66.05	99.57
Short-Term Investments	73.84	26	-	19.67	-
Cash & Short-Term Investments	85.11	147.33	68.79	85.72	99.57
Cash Growth	-42.23%	114.18%	-19.75%	-13.91%	94.75%
Accounts Receivable	-	0.97	0.29	1.1	0.45
Other Receivables	24.61	25.94	23.69	19.79	11.04
Receivables	24.61	26.91	23.98	20.9	11.49
Prepaid Expenses	8.93	13.12	10.39	9.88	5.83
Total Current Assets	118.66	187.37	103.15	116.5	116.9
Property, Plant & Equipment	1.75	1.98	2.31	2.65	2.63
Long-Term Investments	-	-	-	0.34	0.41
Goodwill	10.62	9.39	9.98	9.65	10.28
Other Intangible Assets	0.29	0.31	0.36	0.39	0.03
Other Long-Term Assets	0.13	3.59	3.65	-	-
Total Assets	131.44	202.64	119.45	129.53	130.25
Accounts Payable	4.41	3.7	3.35	3.84	5.5
Accrued Expenses	8.91	12.05	11.72	10.67	8.85
Current Portion of Leases	0.09	0.12	0.23	0.54	0.19
Current Income Taxes Payable	0.04	0.65	0.47	0.71	0.25
Current Unearned Revenue	0.17	0.31	6.57	10.68	5.75
Total Current Liabilities	13.61	16.82	22.34	26.44	20.54
Long-Term Leases	0.07	-	0.12	-	-
Long-Term Unearned Revenue	55.45	51.79	75	76.49	98.17
Total Liabilities	69.14	68.61	97.46	102.93	118.71
Common Stock	10.29	10.29	8.85	6.49	6.08
Additional Paid-In Capital	617.56	609.56	455.77	273.11	249.6
Retained Earnings	-562.57	-474.04	-431.89	-317.2	-301.91
Comprehensive Income & Other	-2.98	-11.78	-10.73	64.19	57.78
Shareholders' Equity	62.3	134.02	21.99	26.59	11.54
Total Liabilities & Equity	131.44	202.64	119.45	129.53	130.25
Total Debt	0.16	0.12	0.35	0.54	0.19
Net Cash (Debt)	84.95	147.22	68.44	85.18	99.39
Net Cash Growth	-42.29%	115.09%	-19.65%	-14.29%	96.17%
Net Cash Per Share	1.80	3.18	1.85	2.65	3.35
Filing Date Shares Outstanding	47.23	47.22	46.5	35.95	29.93
Total Common Shares Outstanding	47.23	47.22	39.62	35.94	29.93
Working Capital	105.05	170.54	80.82	90.06	96.36
Book Value Per Share	1.32	2.84	0.56	0.74	0.39
Tangible Book Value	51.4	124.32	11.65	16.56	1.23
Tangible Book Value Per Share	1.09	2.63	0.29	0.46	0.04
Machinery	5.54	6.34	6.44	6.01	6.92

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.